Understanding the link between HIV and dementia

June 29, 2011 in HIV & AIDS
Understanding the link between HIV and dementia

Enlarge

(Medical Xpress) -- HIV can hide out in the brain, protected from the immune system and antiviral drugs, Dr. Lachlan Gray and his colleagues at Monash University and the Burnet Institute have found.

Their discovery is an important step in understanding the link between and dementia, and is important for the eradication of HIV in general.

“The persistence of the virus in the compromises the brain’s normal function, and leads to the death of neurons and to clinical dementia,” Lachlan says.

In fact, about one in five of those infected by HIV ends up with dementia.

“We believe our findings will aid the development of novel drugs that will prevent HIV using the brain as a sanctuary, and help to shape future eradication strategies.”

Lachlan’s work is being presented for the first time in public through Fresh Science, a communication boot camp for early career scientists held at the Melbourne Museum. He was one of 16 winners from across Australia.

Lachlan has been examining the life cycle of the virus to understand better how it survives within the brain.

“We’ve identified changes in the way the virus reproduces, which allows it to keep a low profile and persist undetected in the brain.”

At present, people living with HIV must rely on the continued use of to control their infection.

“Viral persistence is a major barrier to the cure of AIDS. Modern drugs are very good at controlling the virus, but they are unable to eradicate it from ‘sanctuary’ sites like the brain,” Lachlan’s supervisor, Associate Professor Melissa Churchill says.

“Unfortunately, brain infection often leads to dementia which can be very debilitating. Somewhat more concerning, HIV is now the commonest cause of in people under the age of 40, and is placing an extra burden on our mental health services.”

Lachlan’s research is part of a larger project aiming to trial new drugs that could potentially eradicate or even cure HIV.

Lachlan Gray is one of 16 early-career scientists unveiling their research to the public for the first time thanks to Fresh Science, a national program sponsored by the Australian Government.

Provided by Fresh Science

not rated yet  

Rank not rated yet
Related Stories
Relevant PhysicsForums posts

More news stories

Mortality rates decrease, chronic disease rates increase among HIV+ ICU patients

The expanded use of antiretrovirals, potent drugs used to treat retroviral infections such as human immunodeficiency virus (HIV), has been linked to significant decreases in hospital mortality rates among severely ill HIV-positive(HIV+) ...

HIV & AIDS created May 23, 2012 | popularity not rated yet | comments 0

Newly discovered breast milk antibodies help neutralize HIV

Antibodies that help to stop the HIV virus have been found in breast milk. Researchers at Duke University Medical Center isolated the antibodies from immune cells called B cells in the breast milk of infected mothers in Malawi, ...

HIV & AIDS created May 22, 2012 | popularity 5 / 5 (3) | comments 1 | with audio podcast

Reactions to HIV drug have autoimmune cause, reports AIDS journal

Potentially severe hypersensitivity reactions to the anti-HIV drug abacavir occur through an autoimmune mechanism, resulting from the creation of drug-induced immunogens that are attacked by the body's immune system, according ...

HIV & AIDS created May 22, 2012 | popularity 5 / 5 (1) | comments 0

Is the U.S. ready for home HIV tests?

At the pharmacy, you can buy anything from tea kettles to Tylenol. But what if you could buy a rapid HIV test over the counter and test yourself in the privacy of your own home?

HIV & AIDS created May 21, 2012 | popularity not rated yet | comments 0 | with audio podcast

Reduced glycerin formulation of tenofovir vaginal gel safe for rectal use

A change in the formulation of tenofovir gel, an anti-HIV gel developed for vaginal use, may make it safer to use in the rectum, suggests a study published online this week in the Journal of Antimicrobial Chemotherapy. In lab ...

HIV & AIDS created May 17, 2012 | popularity 5 / 5 (1) | comments 0


Amino acid consumption associated with how fast cancer cells divide

For almost a century, researchers have known that cancer cells have peculiar appetites, devouring glucose in ways that normal cells do not. But glucose uptake may tell only part of cancer's metabolic story. Researchers from ...

'Personality genes' may help account for longevity

"It's in their genes" is a common refrain from scientists when asked about factors that allow centenarians to reach age 100 and beyond. Up until now, research has focused on genetic variations that offer a physiological advantage ...

Gene discovery points towards non-hormonal male contraceptive

A new type of male contraceptive could be created thanks to the discovery of a key gene essential for sperm development.

Thioridazine kills cancer stem cells in human while avoiding toxic side-effects of conventional cancer treatments

A team of scientists at McMaster University has discovered a drug, thioridazine, successfully kills cancer stem cells in the human while avoiding the toxic side-effects of conventional cancer treatments.

Cyber exercise partners help you go the distance: Motivation gains can double

A new study testing the benefits of a virtual exercise partner shows the presence of a moderately more capable cycling partner can significantly boost the motivation – by as much as 100 percent – ...

Brentuximab vedotin effective in large-cell lymphoma

(HealthDay) -- More than half of patients with relapsed or refractory systemic anaplastic large-cell lymphoma (ALCL) treated with the CD30-directed antibody-drug conjugate brentuximab vedotin achieve a complete ...